Abstract
The ABA tri-block copolymer poly(2-methyloxazoline)–poly(dimethylsiloxane)–poly(2-methyloxazoline) (PMOXA–PDMS–PMOXA) is known for its capacity to mimic a bilayer membrane in that it is able to form vesicular polymersome structures. For this reason, it is the subject of extensive research and enables the development of more robust, adaptable and biocompatible alternatives to natural liposomes for biomedical applications. However, the poor solubility of this polymer renders published methods for forming vesicles unreproducible, hindering research and development of these polymersomes. Here we present an adapted, simpler method for the production of PMOXA–PDMS–PMOXA polymersomes of a narrow polydispersity (45 ± 5.8 nm), via slow addition of aqueous solution to a new solvent/polymer mixture. We then magnetically functionalise these polymersomes to form magnetopolymersomes via in situ precipitation of iron-oxide magnetic nanoparticles (MNPs) within the PMOXA–PDMS–PMOXA polymersome core and membrane. This is achieved using electroporation to open pores within the membrane and to activate the formation of MNPs. The thick PMOXA–PDMS–PMOXA membrane is well known to be relatively non-permeable when compared to more commonly used di-block polymer membranes due a distinct difference in both size and chemistry and therefore very difficult to penetrate using standard biological methods. This paper presents for the first time the application of electroporation to an ABA tri-block polymersome membrane (PMOXA–PDMS–PMOXA) for intravesicular in situ precipitation of uniform MNPs (2.6 ± 0.5 nm). The electroporation process facilitates the transport of MNP reactants across the membrane yielding in situ precipitation of MNPs. Further to differences in length and chemistry, a tri-block polymersome membrane structure differs from a natural lipid or di-block polymer membrane and as such the application and effects of electroporation on this type of polymersome is entirely novel. A mechanism is hypothesised to explain the final structure and composition of these biomedically applicable tri-block magnetopolymersomes.
Highlights
Vesicles are micro or nano scale chambers of solution, encapsulated by lipid or polymer
This paper presents a simplified method2f5o6r7the synthesis of monodisperse ABA tri-block polymersomes of PMOXA–PDMS–PMOXA
This paper presents a simplified method for the synthesis of monodisperse ABA tri-block polymersomes of PMOXA–PDMS–PMOXA
Summary
Vesicles are micro or nano scale chambers of solution, encapsulated by lipid (liposomes) or polymer (polymersomes). Reviewing this area of research highlights the high level of adaptability that polymersomes can offer, in terms of their susceptibility to engineering a wide range of functionalisation, and their potential for applications in biomedicine This makes polymersomes an excellent material for use in the production of smarter nanomedical vehicles, as there is the ability to control the in vivo response, solubility, permeability, surface topology and lifetime of the vesicles in a tunable manner [1,3]. Along with the increased block length will lead to significant differences in the rearrangement of the membrane to open pores This change in chemistry, degree of polymerisation and membrane structure should give rise to better encapsulation and maintenance of the polymersome core contents (due to decreased permeability), along with the ability to stabilise and functionalise the vesicle by adaptation of reactive end groups. This leads to a decrease in permeability and the eventual formation of extended structural networks within the vesicular membrane, making the polymersomes highly stable and robust (e.g., to changes in temperature) [29]
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have